With the potential to cure genetic disorders rather than just alleviate symptoms, gene therapies look set to revolutionize the field of medicine. Adeno-associated viruses have emerged as the vector of choice for delivering therapeutic genes to target cells, but manufacturing processes need to be improved and optimized to unlock their full potential.
In this feature, we discuss the significant progress made in our ability to deliver therapeutic genes to target cells – and the many challenges on the road ahead.
Complete this form to access the article.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
